Applied Therapeutics, Inc. (APLT)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
Loading interactive chart...
- Motley Fool
Why Applied Therapeutics Stock Is Sliding Today
The company's lead candidate, AT-007, is going to take a lot longer to reach patients than expected.
- GlobeNewswire
Applied Therapeutics Provides Regulatory Update on Galactosemia Program
NEW YORK, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today provided a regulatory update on the AT-007 Galactosemia program. Following discussions with the FDA at the end of the year, the Company has decided to hold on submitting an NDA for AT-007 for treatment of Galactosemia pending additional d
- Investing.com
Applied Therapeutics Tanks as Drug Candidate for Rare Disease Faces Delays
By Dhirendra Tripathi
